User: Guest  Login
Title:

Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.

Document type:
Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Author(s):
Baur, DM; Klotsche, J; Hamnvik, OP; Sievers, C; Pieper, L; Wittchen, HU; Stalla, GK; Schmid, RM; Kales, SN; Mantzoros, CS
Abstract:
There is growing evidence that patients with type 2 diabetes mellitus have increased cancer risk. We examined the association between diabetes, cancer, and cancer-related mortality and hypothesized that insulin sensitizers lower cancer-related mortality. Participants in the Diabetes Cardiovascular Risk and Evaluation: Targets and Essential Data for Commitment of Treatment study, a nationwide cross-sectional and prospective epidemiological study, were recruited from German primary care practices....     »
Journal title abbreviation:
Metabolism
Year:
2011
Journal volume:
60
Journal issue:
10
Pages contribution:
1363-71
Language:
eng
Fulltext / DOI:
doi:10.1016/j.metabol.2010.09.012
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/21081242
Print-ISSN:
0026-0495
TUM Institution:
II. Medizinische Klinik und Poliklinik (Gastroenterologie)
 BibTeX